On July 28, 2018, David Rubin, MD, FACG, AGAF, FACP, tweeted a photo of the receipt that one of his patients with ulcerative colitis received after purchasing one month’s worth of mesalamine (Rowasa) 5-aminosalicylic acid (5-ASA) enemas. The cost: $695.89.
“Two issues [with] this,” tweeted Dr. Rubin, the chief of the Section of Gastroenterology, Hepatology and Nutrition, and co-director of the Digestive Diseases Center at the University of Chicago, who tweets with the handle